UBS raised the firm’s price target on American Express (AXP) to $320 from $283 and keeps a Neutral rating on the shares. A re-acceleration in spend, either among U.S. consumer or commercial cardmembers, is likely needed for AmEx to get revenue growth on the mid-to-upper end of 2024’s initial 9%-11% guidance, the analyst tells investors in a research note. The extent of a rebound on the commercial side may take longer, the firm says, adding that revenue guidance below the 9%-11% range may disappoint the Street.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXP:
- Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
- DOJ sues to block Global Business Travel’s proposed takeover of CWT Holdings
- U.S. sues to block AmEx Global Business Travel merger with CWT, Bloomberg says
- DAL Earnings: Delta Airlines Soars on Robust Q4 Earnings and Upbeat Outlook
- Delta Air Lines (DAL) Switches Ride-Hailing Partner from Lyft to Uber